GSK has been found guilty of bringing discredit on the pharma industry after a complainant flagged “a shocking error” in the prescribing information for the JAK inhibitor Omjjara. A person who ...

In October, GSK said it had spent $2.2bn settling 93% of the cases without admitting liability. But in a lawsuit filed with the US district court in Pennsylvania, the Roofers Local No149 Pension ...